Galaxy Diagnostics is a trusted One Health company specializing in providing reliable results for flea and tick-borne pathogens. With a focus on developing novel assays, they offer highly sensitive and specific tests for diseases such as Bartonella, Borrelia (Lyme Disease), and Babesia. Their scientific expertise is evident through their dedicated management and research teams.

As a leader in the field, Galaxy Diagnostics goes beyond the limits of detection. They offer a range of products and services to various sectors. For providers, they provide DNA and antibody tests that lead to more accurate diagnoses.

Veterinarians can benefit from their services as both animals and professionals are at a high risk for Bartonella infections. Additionally, researchers can rely on Galaxy Diagnostics for contract research services to support their work. Galaxy Diagnostics' advanced testing methodologies directly detect DNA or proteins of flea and tick-borne pathogens, allowing them to confirm infections that are often missed by conventional methods.

With a mission to research, educate, and build awareness for vector-borne diseases, they are dedicated to enhancing their direct detection capabilities and furthering the clinical understanding of these diseases through collaborations with leading research institutions. Overall, Galaxy Diagnostics is committed to providing advanced testing that helps diagnose flea and tick-borne diseases in both humans and pets